Business Performance - In Q3 2021, the company experienced strong order volume and secured significant new business mandates, despite facing delays due to U.S. government funding uncertainties and COVID-19 impacts [201]. - Revenues increased 162% to 32.7millionforQ32021comparedto12.5 million for Q3 2020, with acquisitions contributing 16.9million,representing135(31.1) million, compared to (2.9)millioninQ32020,reflectinga987(24.3) million, a 938% increase compared to (2.3)millioninQ32020[223].−RevenuesfortheninemonthsendedSeptember30,2021increased44796.5 million compared to 17.7millionforthesameperiodin2020,drivenbyacquisitionscontributing49.9 million [235]. Cost and Expenses - Cost of sales as a percentage of net revenues decreased to 82% in Q3 2021 from 84% in Q3 2020, with a 154% increase in cost of sales attributed to acquisitions [225]. - SG&A expenses as a percentage of revenues rose to 105% in Q3 2021 from 28% in Q3 2020, with a significant portion due to equity-based compensation and public company readiness expenses [226]. - Research and development expenses as a percentage of revenues decreased to 5% in Q3 2021 from 6% in Q3 2020, focusing on next-generation technologies [229]. - Interest expense, net increased to 5% of revenues in Q3 2021 from 1% in Q3 2020, primarily due to outstanding debt [230]. - Income tax expense as a percentage of revenues was 17% in Q3 2021, up from 5% in Q3 2020, influenced by nondeductible transaction costs [232]. Acquisitions and Partnerships - The company completed the merger with Genesis Park Acquisition Corp. and began trading on the NYSE on September 3, 2021 [203]. - The company acquired Techshot, Inc. for cash and stock, enhancing its capabilities in microgravity bioprinting and on-orbit manufacturing [213]. - The company has partnered with leading space companies on the Orbital Reef project, a proposed commercial ecosystem in low Earth orbit [203]. - The company has been integrating several acquisitions from a fragmented landscape of space-focused technology companies to enhance its innovative capabilities [199]. Contracts and Backlog - Contracted backlog as of September 30, 2021, totaled 121.4million,aslightdecreasefrom122.3 million as of December 31, 2020 [261]. - Organic backlog at the end of the period was 32.6million,downfrom52.6 million at the beginning of the period, reflecting higher organic revenue recognized [261]. - Acquisition-related backlog increased to 88.8millionasofSeptember30,2021,comparedto69.7 million at the end of the previous period [261]. - Total backlog, including both contracted and uncontracted backlog, reached 284.6millionasofSeptember30,2021,withuncontractedbacklogat163.3 million [264]. Financial Position and Liquidity - Available liquidity as of September 30, 2021, was 32.3million,consistingof27.3 million in cash and cash equivalents, and 5.0millioninavailableborrowings[270].−TotaldebtasofSeptember30,2021,was80.5 million, an increase from 78.6millionasofDecember31,2020[271].−Thecompanyincurrednetlossesandnegativeoperatingcashflowsinceinception,impactingitscashmanagementstrategy[266].−TheAdamsStreetCreditAgreementhasamaturitydateofOctober28,2026,andrequirescompliancewithcustomarycovenants[274].−AsofSeptember30,2021,totalcontractualobligationsamountedto98.2 million, with long-term debt maturities contributing 80.5millionandfutureminimumleasepaymentstotaling17.7 million [285]. Cash Flow Activities - For the Successor 2021 Period, net cash used in operating activities was 34.3million,primarilyduetoanetlossof18.5 million and an unfavorable change in net working capital of 15.8million[287].−NetcashusedininvestingactivitiesfortheSuccessor2021Periodwas36.1 million, mainly for the acquisitions of Oakman and DPSS, totaling 38.7million[290].−NetcashprovidedbyfinancingactivitiesfortheSuccessor2021Periodwas75.5 million, driven by proceeds from debt of 49.0millionandmergerproceedsof110.6 million [292]. - The net increase in cash and cash equivalents for the Successor 2021 Period was 5.2million,resultingincashandcashequivalentsof27.3 million at the end of the period [286]. Operational Challenges - The company continues to monitor the impacts of COVID-19 on operations, with uncertainties regarding program execution and supply chain stress [220]. - The unfavorable change in net working capital during the Successor 2021 Period was largely driven by increases in accounts receivable (1.2million)andcontractassets(3.5 million) [287]. Accounting and Estimates - The company regularly evaluates critical accounting estimates, which can significantly impact net revenues and expenses, based on historical experience and reasonable assumptions [295].